31. January 2024
Orifarm adjusts its operating model to become even more customer focused and agile
Following the successful integration of assets and people from Takeda, Orifarm will now simplify the business model.
“Since the acquisition of the Takeda assets almost three years ago, Orifarm has changed quite significantly. We have integrated new businesses, we expanded into new geographies, and we welcomed many new colleagues. The combined effort of everyone in Orifarm has taken us far, and today we have a strong platform for continuous growth,” says CEO Erik Sandberg.
A significant change will be the merger of the two business areas, Health Access and Healthcare, as they will be combined into one business area.
“In order to sharpen our profile and offering towards our customers will we merge our two commercial business units into one, ensuring that we face the customers as one unified commercial organization,” says Erik Sandberg.
To match the new commercial set up, Orifarm has decided to combine supply chains into one business unit covering sourcing and supply chain. Finally, Orifarm will adjust the rest of the organization to match the commercial setup and ensure efficient processes and an agile organization ready to respond to customer’s need.
“With this restructuring we would like to prepare Orifarm for future growth by ensuring one face to the customer and operating in a more agile and lean organization,” says Erik Sandberg.
Changes to the Executive Management Group
As a consequence of the new organizational structure, a few changes to the Executive Management Group have been implemented.
The combined commercial business unit will be headed by Thomas Brandhof, who will assume the role as Chief Commercial Officer, responsible for the entire portfolio and markets. Thomas was previously Chief Commercial Officer in Orifarm´s Health Access business unit..
Thomas Hedegaard has been promoted and will assume the position as Chief Sourcing Officer. Thomas was previously Vice President of Procurement in Orifarm’s Health Access business unit. The role as Chief Sourcing Officer is new in Orifarm, and Thomas will play a vital role in leading and developing an end-to-end supply chain, covering both the former Health Access and Healthcare business units.
There will be no changes to support functions, except that Corporate Communications will move to Global People & Culture headed by Chief People Officer, Andreas Friis. Consequently, VP, Corporate Communication Kristian Lysgaard steps out of EMG.
Unfortunately, the changes also mean that Chief Commercial Officer, Orifarm Healthcare, Dennis Dencher, will leave Orifarm as his position is terminated.
“It is with regret, we have to say goodbye to Dennis. He has been deeply involved in integrating the assets we acquired from Takeda, including welcoming more than 600 people and ensuring a successful integration. Dennis can be immensely proud of his significant contribution, and I wish him all the best going forward,” says CEO Erik Sandberg.
The new Executive Management Group
Chief Executive Officer Erik Sandberg
Chief Financial Officer Jacob Berg Lucassen
Chief Commercial Officer Thomas Brandhof
Chief Sourcing Officer Thomas Hedegaard
Chief People Officer Andreas Friis
Chief Information Officer Klaus Mortensen
Chief Corporate Compliance Officer Birgitte Røddik
Corporate Development Officer Ulrik Markussen
Read more here